Navigation Links
Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
Date:6/16/2011

LEXINGTON, Mass., June 16, 2011 /PRNewswire-USNewswire/ -- Cubist Pharmaceuticals, Inc. today praised Rep. Phil Gingrey, R-Ga., and co-sponsors for introducing the Generating Antibiotic Incentives Now (GAIN) Bill of 2011. This critical piece of legislation was crafted to help restore a robust antibiotic development pipeline to address the growing public health threat due to emerging multi-drug-resistant (MDR) bacteria.

The bi-partisan legislation calls for the enactment of specific economic and market incentives to entice pharmaceutical companies to develop new antibiotics to treat the growing number of serious infections caused by MDR bacteria. For example, the legislation's provision for extending the exclusivity granted to some badly-needed antibiotics is designed to have the same impact on antibiotic R&D as the Orphan Drug Act had on drugs to treat rare diseases, which now enjoy a healthy pipeline.

"Cubist Pharmaceuticals applauds Congressman Gingrey and his colleagues for their foresight in bringing the GAIN Bill forward," said Michael Bonney, President and CEO of Cubist Pharmaceuticals. "The antibiotic development pipeline is in danger of running dry.  Without policies to reverse this market failure, our public health system is at risk of increased treatment costs in the vicinity of $20 billion a year. In addition, our national security can be vulnerable to a bio-terrorist attack using antibiotic-resistant organisms."

The Infectious Diseases Society of America (IDSA), which represents physicians, scientists and other health care professionals who specialize in infectious diseases, estimates there are 100,000 U.S. deaths each year from hospital-acquired infections due mostly to antibiotic-resistant pathogens. To help spur the pipeline, IDSA released the "Bad Bugs Need Drugs 10x20" plan, an initiative promoting the introduction of 10 new antibiotics into the U.S. market by 2020. The GAIN Bill supports this goal by bringing new i
'/>"/>

SOURCE Cubist Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution
2. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013   National Community Pharmacists Association ... RPh, MBA issued the following statement today regarding a ... Part D "preferred pharmacy" drug plans , which ... plan,s lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... , May 20, 2013  TRACE International today ... 2012 , finding that prosecutions against individuals and government ... last year. The GER 2012 is the ... international anti-bribery enforcement trends. "Although the number ... of bribery laws remained a priority," said ...
(Date:5/20/2013)... , May 20, 2013   Life Technologies ... that its Applied Biosystems™ 3500 Dx and 3500xL Dx ... for Protection against Health Risks in Mexico ... major extension of Life Technologies, capabilities to serve the ... with Sanger -based solutions.  ...
Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3
... both ethical and practical grounds, direct programming is ... pluripotent stem,cells.", WASHINGTON, Nov. 20 Two ... Cell unveil a proven way to,generate patient-matched human ... use of human embryos or human or animal ...
... of circulating cancer cells in 40,billion blood cells, ... WARREN, N.J., Nov. 20 Veridex, LLC ... (FDA) has granted an,expanded clearance for the CellSearch(TM) ... monitoring of metastatic colorectal cancer. CellSearch is currently,approved ...
Cached Medicine Technology:Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 2FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 3FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 4
(Date:5/20/2013)... McLean, VA (PRWEB) May 20, 2013 ... (EDRA) Annual Conference will feature dozens of continuing ... approved by the American Institute of Architects Continuing ... System (LA CES), and the Interior Design Continuing ... May 29 – June 1, 2013 at the ...
(Date:5/20/2013)... Co-founder of Atlanta SEO company ... at the 5th International INVEST Domaining & Internet Marketing ... company representatives and independent individuals from around the world ... investments. , The 2013 conference will take place at ... May 20 to 21. A networking city tour day ...
(Date:5/20/2013)... May 20, 2013 The judge overseeing ... lawsuits has called specifically for female lawyers to be ... The Rottenstein Law Group LLP acknowledges the judge’s request, ... lawsuits by providing information on Mirena side effects ... Seibel called for the addition of some female lawyers ...
(Date:5/20/2013)... Branch at Galveston researchers have been awarded a five-year, ... Disorders and Stroke to apply the techniques of gene ... is, pain that arises from a malfunction in the ... reality for millions of Americans, manifesting itself in a ... might feel intense discomfort in response to a light ...
(Date:5/20/2013)... 20, 2013 Dorland Health, a ... the fourth annual Case In Point Platinum Awards, ... to ensuring the system is patient- and family-centric, ... innovative and creative work across the healthcare system ... safe transitions of care through effective care coordination ...
Breaking Medicine News(10 mins):Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Pain, pain, go away 2Health News:Pain, pain, go away 3Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2
... ... Announced by ERISAclaim.com for Healthcare Providers to Appeal Claim Denials and Delays, to Comply with ... Plans And Healthcare Providers. , ... Hanover Park, IL (PRWEB) June 28, 2010 -- ERISAclaim.com announced the nation,s first new ...
... ... that provides a comprehensive view of California public policy and legislative issues. Available ... one site. , ... 28, 2010 -- The ‘LegisWeb Eye’ launches on July 1st, bringing a new legislative information ...
... lowered the obesity rate in students at highest risk for ... in sixth grade, an NIH-funded study has found. However, ... schools in the study,s primary outcomethe prevalence of overweight and ... schools by the end of the three-year study. The ...
... ... Tarot Professionals Ltd establishes Tarosophy® Tarot Houses worldwide ... being prepared to warn Tarot readers by highlighting certification scams, bad ... field. Tarot Professionals Ltd continues to introduce innovative Tarot courses – ...
... People with type 1 diabetes who have early and ... in the urine, are six times more likely to die ... of Pittsburgh Graduate School of Public Health. Their study, being ... Association, also found that when kidneys remained normal over time, ...
... , ... Henninger Media Services, the largest production/post-production company in the Mid-Atlantic region, acquires premiere ... Clients include National Geographic Films, Discovery Networks and various documentary filmmakers. ... (PRWEB) ...
Cached Medicine News:Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 2Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 3Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 4Health News:The 'LegisWeb Eye' Legislative Web Portal Launches on July 1st 2Health News:The 'LegisWeb Eye' Legislative Web Portal Launches on July 1st 3Health News:Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds 2Health News:Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds 3Health News:Tarosophy Deals A Fair Hand for All Tarot Seekers 2Health News:Tarosophy Deals A Fair Hand for All Tarot Seekers 3Health News:Tarosophy Deals A Fair Hand for All Tarot Seekers 4Health News:Henninger Media Services Now Offers Hollywood-Quality Blu-ray Products 2Health News:Henninger Media Services Now Offers Hollywood-Quality Blu-ray Products 3
The ultimate combination of comfort, convenience and affordability, recommended for daily wear, also approved for extended wear (1-7 days)....
Acuvue2 is designed to be worn as a two-week daily wear lens (which means you take the lenses out each night). It can also be worn as a one-week extended wear lens (which means you can sleep in them)...
... water content spherical soft lens manufactured using ... molding technology, and designed for use in ... a daily wear or extended wear basis. ... transmission, while an increased mid-peripheral thickness allows ...
Hertel exophthalmometer...
Medicine Products: